CompletedNot Applicable

Imaging of Vitreous Opacities in a Canadian Population

Canada44 participantsStarted 2024-11-12

Plain-language summary

The goal of this clinical trial is to capture imaging data of eye floaters in the population to build an imaging database to learn more about them in. Participants will imaged with an investigational ophthalmic imaging device to capture images of their floaters.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Aged 18 years or older * Symptomatic vitreous opacities (floaters) in vision * Clear ocular media, to allow a clear view of the vitreous for the SVO-ID Exclusion Criteria: * Younger than 18 years of age * Presence of vitreous hemorrhage * Cataract Grade 3 and above * Opacification of lens, cornea, or vitreous * Diagnosis of narrow angle glaucoma * Refractive error is outside the range of -6D to+3D * Astigmatism is outside the range of +/-2D of cylinder

What they're measuring

Successful capture of SLO and OCT imaging data of SVOs for algorithm development

Timeframe: Through study completion, an average of 6-8 months

Trial details

NCT IDNCT06204848

SponsorPulseMedica

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2025-07-31

View on ClinicalTrials.gov More Floaters trials